Zobrazeno 1 - 10
of 1 046
pro vyhledávání: '"Neil E. Kay"'
Autor:
Juan G. Ripoll, Sidna M. Tulledge-Scheitel, Anthony A. Stephenson, Shane Ford, Marsha L. Pike, Ellen K. Gorman, Sara N. Hanson, Justin E. Juskewitch, Alex J. Miller, Solomiia Zaremba, Erik A. Ovrom, Raymund R. Razonable, Ravindra Ganesh, Ryan T. Hurt, Erin N. Fischer, Amber N. Derr, Michele R. Eberle, Jennifer J. Larsen, Christina M. Carney, Elitza S. Theel, Sameer A. Parikh, Neil E. Kay, Michael J. Joyner, Jonathon W. Senefeld
Publikováno v:
mBio, Vol 15, Iss 5 (2024)
ABSTRACTAlthough severe coronavirus disease 2019 (COVID-19) and hospitalization associated with COVID-19 are generally preventable among healthy vaccine recipients, patients with immunosuppression have poor immunogenic responses to COVID-19 vaccines
Externí odkaz:
https://doaj.org/article/ecf5af76d7154c2cbf889ff5abdea430
Autor:
Gordon J. Ruan, Xiaosheng Wu, Kimberly A. Gwin, Michelle K Manske, Jithma P. Abeykoon, Vaishali Bhardwaj, Taylor L. Witter, Matthew J. Schellenberg, Kari G Rabe, Neil E. Kay, Sameer A. Parikh, Thomas E. Witzig
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The open reading frame 8 (ORF8) protein, encoded by the SARS-CoV-2 virus after infection, stimulates monocytes/macrophages to produce pro-inflammatory cytokines. We hypothesized that a positive ex vivo monocyte response to ORF8 protein pre-COVID-19 w
Externí odkaz:
https://doaj.org/article/01329c39a20f4a1cb4a1181ddc685ff6
Autor:
Jonathon W. Senefeld, PhD, Ellen K. Gorman, BS, Patrick W. Johnson, BS, M. Erin Moir, PhD, Stephen A. Klassen, PhD, Rickey E. Carter, PhD, Nigel S. Paneth, MD, David J. Sullivan, MD, Olaf H. Morkeberg, BA, R. Scott Wright, MD, DeLisa Fairweather, PhD, Katelyn A. Bruno, PhD, Shmuel Shoham, MD, Evan M. Bloch, MBChB, MS, Daniele Focosi, MD, Jeffrey P. Henderson, MD, PhD, Justin E. Juskewitch, MD, PhD, Liise-Anne Pirofski, MD, Brenda J. Grossman, MD, MPH, Aaron A.R. Tobian, MD, PhD, Massimo Franchini, MD, Ravindra Ganesh, MBBS, MD, Ryan T. Hurt, MD, PhD, Neil E. Kay, MD, Sameer A. Parikh, MBBS, Sarah E. Baker, PhD, Zachary A. Buchholtz, BS, Matthew R. Buras, BS, Andrew J. Clayburn, BS, Joshua J. Dennis, BS, Juan C. Diaz Soto, MD, Vitaly Herasevich, MD, PhD, Allan M. Klompas, MB, BCh, BAO, Katie L. Kunze, PhD, Kathryn F. Larson, MD, John R. Mills, PhD, Riley J. Regimbal, BS, Juan G. Ripoll, MD, Matthew A. Sexton, MD, John R.A. Shepherd, MD, James R. Stubbs, MD, Elitza S. Theel, PhD, Camille M. van Buskirk, MD, Noud van Helmond, MD, Matthew N.P. Vogt, MD, Emily R. Whelan, BS, Chad C. Wiggins, PhD, Jeffrey L. Winters, MD, Arturo Casadevall, MD, PhD, Michael J. Joyner, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 5, Pp 499-513 (2023)
Objective: To examine the association of COVID-19 convalescent plasma transfusion with mortality and the differences between subgroups in hospitalized patients with COVID-19. Patients and Methods: On October 26, 2022, a systematic search was performe
Externí odkaz:
https://doaj.org/article/dadeeaf646b74fc8991c25a417a35f18
Autor:
Baustin M. Welch, Bryce A. Manso, Kimberly A. Gwin, Petra K. Lothert, Sameer A. Parikh, Neil E. Kay, Kay L. Medina
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of CD19+ CD5+ clonal B lymphocytes in the blood, bone marrow, and peripheral lymphoid organs. Treatment options for patients range from historical chemoimmunotherapy (CIT) to sma
Externí odkaz:
https://doaj.org/article/3af2d62a88864d4880ba353b1c54c869
Autor:
Paul J. Hampel, Kari G. Rabe, Timothy G. Call, Wei Ding, Jose F. Leis, Asher A. Chanan-Khan, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Sikander Ailawadhi, Amber B. Koehler, Ricardo Parrondo, Susan M. Schwager, Taimur Sher, Curtis A. Hanson, Min Shi, Daniel L. Van Dyke, Esteban Braggio, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 9, Pp 1-6 (2022)
Abstract Patients with chronic lymphocytic leukemia (CLL) with disease progression on ibrutinib have worse outcomes compared to patients stopping ibrutinib due to toxicity. A better understanding of expected outcomes in these patients is necessary to
Externí odkaz:
https://doaj.org/article/c5ee38417b3b4e7f8218d469cd1ba54f
Autor:
Sameer A. Parikh, Sara J. Achenbach, Kari G. Rabe, Aaron D. Norman, Nicholas J. Boddicker, Janet E. Olson, Timothy G. Call, James R. Cerhan, Celine M. Vachon, Neil E. Kay, Esteban Braggio, Curtis A. Hanson, Susan L. Slager, Tait D. Shanafelt
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 11, Pp 1-3 (2022)
Externí odkaz:
https://doaj.org/article/84ef60e8cb4d400eaa21e2c7b68110e9
Autor:
Zhiquan Wang, Huihuang Yan, Justin C. Boysen, Charla R. Secreto, Renee C. Tschumper, Dania Ali, Qianqian Guo, Jian Zhong, Jiaqi Zhou, Haiyun Gan, Chuanhe Yu, Diane F. Jelinek, Susan L. Slager, Sameer A. Parikh, Esteban Braggio, Neil E. Kay
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 7, Pp 1-11 (2022)
Abstract Constitutively activated B cell receptor (BCR) signaling is a primary biological feature of chronic lymphocytic leukemia (CLL). The biological events controlled by BCR signaling in CLL are not fully understood and need investigation. Here, b
Externí odkaz:
https://doaj.org/article/7597417fd55e4c63aa326e2f821ea603
Autor:
Rebecca L. King, Alia Gupta, Paul J. Kurtin, Wei Ding, Timothy G. Call, Kari G. Rabe, Saad S. Kenderian, Jose F. Leis, Yucai Wang, Susan M. Schwager, Susan L. Slager, Neil. E. Kay, Amber Koehler, Stephen M. Ansell, David J. Inwards, Thomas M. Habermann, Min Shi, Curtis A. Hanson, Matthew T. Howard, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract The distinction between chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with isolated Hodgkin/Reed–Sternberg cells (CLL-HRS; background milieu with a paucity of inflammatory cells) and overt transformation to classic Hodg
Externí odkaz:
https://doaj.org/article/989c3e3359c44e3abd2c16b6d6766da6
Autor:
Yucai Wang, Sara J. Achenbach, Kari G. Rabe, Tait D. Shanafelt, Timothy G. Call, Wei Ding, Saad S. Kenderian, Eli Muchtar, Jose F. Leis, Amber B. Koehler, Susan M. Schwager, James R. Cerhan, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 8, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/863bb1613c0f4313b4f20f6c1c59d34d
Autor:
Yucai Wang, Sutapa Sinha, Linda E. Wellik, Charla R. Secreto, Karen L. Rech, Timothy G. Call, Sameer A. Parikh, Saad S. Kenderian, Eli Muchtar, Suzanne R. Hayman, Amber B. Koehler, Daniel L. Van Dyke, Jose F. Leis, Susan L. Slager, Haidong Dong, Neil E. Kay, Rong He, Wei Ding
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-9 (2021)
Abstract Richter syndrome (RS) refers to transformation of chronic lymphocytic leukemia (CLL) to an aggressive lymphoma, most commonly diffuse large B-cell lymphoma. RS is known to be associated with a number of genetic alterations such as TP53 and N
Externí odkaz:
https://doaj.org/article/6b326bb24b624e97b5dc1e2dce130e5f